Viewing Study NCT06524271



Ignite Creation Date: 2024-10-25 @ 7:52 PM
Last Modification Date: 2024-10-26 @ 3:36 PM
Study NCT ID: NCT06524271
Status: COMPLETED
Last Update Posted: None
First Post: 2024-07-23

Brief Title: Effect of Fermented Soybean FSB Supplementation on Gas-troesophageal Reflux Disease GERD
Sponsor: None
Organization: None

Study Overview

Official Title: Effect of Fermented Soybean FSB Supplementation on Gas-troesophageal Reflux Disease GERD
Status: COMPLETED
Status Verified Date: 2024-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Gastroesophageal reflux disease GERD is a prevalent chronic condition affecting the well-being of both adults and children in general medical practice Research on the effects of fermented soy-bean FSB supplementation in managing GERD is relatively new with limited studies available Existing research often lacks sufficient dosing regimens and study durations to differentiate be-tween transient placebo effects and sustained benefits In this study the beneficial effects of FSB supplementation were investigated in 50 voluntary participants Participants were required to take 1g of FSB supplement once daily for twelve weeks GERD symptoms were evaluated using the Reflux Disease Questionnaire RDQ while inflammatory markers including interleukin-4 IL-4 interleukin-6 IL-6 and interleukin-8 IL-8 were measured to assess inflammation The Quality of Life in Reflux and Dyspepsia QOLRAD questionnaire was used to evaluate partici-pants quality of life Results indicated that FSB supplementation significantly P005 alleviated heartburn and regurgitation symptoms and reduced levels of IL-4 IL-6 and IL-8 indicating a notable anti-inflammatory effect Additionally significant P005 improvements were observed in QOLRAD scores particularly in vitality emotional distress and physicalsocial functioning Collectively our findings support the use of FSB as an adjuvant approach in managing GERD with notable improvements in patients quality of life
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None